DERIVES DE L'ANDROSTENE

Patent europeic · EP0902789 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0902789
Numer da la dumonda
EP97921345
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
01-05-1997
Publitgà
24-03-1999
Concedì
23-01-2002
Stritgà
31-05-2009
Motiv
Taxa annuala betg pajada
Classas IPC
C07J 3/00 (2006.01)
A61K 31/56 (2006.01)
Prioritad
US 17102 P 09.05.1996
Dumonda PCT
PCT/US1997/006812 01.05.1997
Publicaziun PCT
WO1997/042214 13.11.1997
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-12-2009

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.12.2009

  2. 15-03-2005

    Transferì

    Owner
    Soft Drugs, Inc., 6219 S.W. 93rd Avenue, Gainesville, FL 32608, USA → IVAX International GmbH, St. Leonhardstrasse 20, Postfach 327, 9001 St. Gallen

    Published in +pat+ No 5 in 2005

  3. 14-06-2002

    Represchentant inscrit

    Representative
    Kirker & Cie SA, 122, rue de Genève, Case postale 65, 1226 Thônex (Genève)

    Published in PIDTJ No 11 in 2002

  4. 31-01-2002

    Concedì

    Published in PIDTJ No 2 in 2002

Partidas

Inventur

BODOR, Nicholas, S.

Gainesville, FL 32608, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.